Yang Jinshuo, Wu Qiaowei, Yuan Kaikun, Zhang Guang, Xu Chao, Dai Jiaxing, Du Yiming, Sun Bowen, Zhu Yujing, Lan Shuai, Shi Huaizhang, Xu Shancai
Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Quant Imaging Med Surg. 2024 Dec 5;14(12):8878-8888. doi: 10.21037/qims-24-1147. Epub 2024 Nov 29.
Cases of ruptured distal intracranial aneurysms (DIAs) in the posterior circulation are rare. Currently, the most commonly used approach in clinical practice to treat this condition is reconstructive endovascular treatment. However, research on endovascular treatment of intracranial posterior circulation ruptured DIAs is currently lacking. This study aimed to analyze the safety and efficacy of reconstructive endovascular treatment for DIAs in the posterior circulation.
A retrospective cohort study was conducted on patients with ruptured distal posterior circulation aneurysms who underwent endovascular reconstructive treatment at The First Affiliated Hospital of Harbin Medical University from September 2014 to August 2023. We collected and analyzed the patients' characteristics, clinical outcomes, and angiographic follow-up results. Complications were determined and recorded based on the patients' hospital records and imaging examination results. Clinical information was collected through neurological assessments and follow-up telephone interviews. Follow-up angiographic evaluations using digital subtraction angiography (DSA) were planned for 6 months after the procedure until 1-year postprocedure.
The procedure was successfully performed on all 49 patients. Among the patients, 16 (32.7%) were males. The mean age of all patients was 59.0±12.7 years. A total of 15 (30.6%) patients used stent-assisted coiling. During hospitalization, 16 (32.7%) patients experienced complications, including 6 with hemorrhagic complications, 7 with ischemic complications, and 4 with shunt-dependent hydrocephalus. One patient had both shunt-dependent hydrocephalus and ischemic complications. Three (6.1%) patients died during hospitalization, all related to aneurysm rebleeding. All patients underwent clinical follow-up, with a median follow-up time of 39 months [interquartile range (IQR), 21.0-70.5 months]. At the last follow-up, 42 (85.7%) patients had a modified Rankin scale score of 0-2. During the follow-up period, one patient died, resulting in an overall mortality rate of 8.2% (4/49). A total of 35 surviving patients underwent angiographic follow-up, with a follow-up rate of 76.1% (35/46) and a median follow-up time of 8.5 months (IQR, 6.0-12.0 months). Among the follow-up patients, 94.3% were classified as Raymond-Roy grade 1-2, and two patients experienced residual aneurysm. Survival analysis showed a 1-year complication-free survival rate of 69.4% and a 1-year overall survival rate of 89.3%.
This study found that the incidence of complications during hospitalization was relatively high. However, the clinical follow-up results were satisfactory, and imaging follow-up demonstrated a high aneurysm occlusion rate. In summary, endovascular treatment of ruptured DIAs in the posterior circulation is feasible, safe, and effective, but attention should still be paid to the occurrence of related complications.
颅内后循环远端动脉瘤(DIA)破裂的病例较为罕见。目前,临床实践中治疗这种疾病最常用的方法是重建性血管内治疗。然而,目前缺乏关于颅内后循环破裂DIA的血管内治疗研究。本研究旨在分析重建性血管内治疗后循环DIA的安全性和有效性。
对2014年9月至2023年8月在哈尔滨医科大学附属第一医院接受血管内重建治疗的后循环远端动脉瘤破裂患者进行回顾性队列研究。我们收集并分析了患者的特征、临床结局和血管造影随访结果。根据患者的医院记录和影像学检查结果确定并记录并发症。通过神经学评估和随访电话访谈收集临床信息。计划在术后6个月至术后1年使用数字减影血管造影(DSA)进行随访血管造影评估。
49例患者均成功完成手术。其中男性16例(32.7%)。所有患者的平均年龄为59.0±12.7岁。共有15例(30.6%)患者采用支架辅助弹簧圈栓塞术。住院期间,16例(32.7%)患者出现并发症,其中出血性并发症6例,缺血性并发症7例,分流依赖性脑积水4例。1例患者同时出现分流依赖性脑积水和缺血性并发症。3例(6.1%)患者在住院期间死亡,均与动脉瘤再出血有关。所有患者均接受临床随访,中位随访时间为39个月[四分位间距(IQR),21.0 - 70.5个月]。在最后一次随访时,42例(85.7%)患者的改良Rankin量表评分为0 - 2分。随访期间,1例患者死亡,总死亡率为8.2%(4/49)。共有35例存活患者接受了血管造影随访,随访率为76.1%(35/46),中位随访时间为8.5个月(IQR,6.0 - 12.0个月)。在随访患者中,94.3%被归类为Raymond - Roy 1 - 2级,2例患者存在残余动脉瘤。生存分析显示1年无并发症生存率为69.4%,1年总生存率为89.3%。
本研究发现住院期间并发症发生率相对较高。然而,临床随访结果令人满意,影像学随访显示动脉瘤闭塞率较高。总之,后循环破裂DIA的血管内治疗是可行、安全和有效的,但仍应注意相关并发症的发生。